Walgreens stock tumbles on report that private equity deal is unlikely
Shares of Walgreens Boots Alliance tumbled today following a CNBC report that the Deerfield-based pharmacy chain was unlikely to sell itself to a private-equity firm. CNBC’s David Faber reported on air this morning that sources say the possible deal in which Walgreens would sell itself to New York-based Sycamore Partners is “mostly dead.”
Walgreens Boots (NASDAQ:WBA) rose 1.6% after the drugstore chain's CEO responded to recent takeover speculation. Walgreens ...
Pharmacy chain Walgreens has been struggling for over a year and has been in talks to sell to Sycamore Partners, a deal that is now "mostly dead." Meanwhile, some independent pharmacies are opting to ...
Sources told CNBC's David Faber that a private equity firm's prospective deal to acquire Walgreens Boots Alliance is ...
Analyst Michael Cherny of Leerink Partners reiterated a Hold rating on Walgreens Boots Alliance (WBA – Research Report), retaining the price ...
Walgreens continues to discount that report ... drive long-term value indicate that the rumored sale to PE firm Sycamore Partners is less likely." Mizuho Securities USA analyst Ann Hynes, too ...
Advocate Health is shuttering 55 clinics inside Walgreens stores in Illinois and Wisconsin, effective Feb. 6.
CNBC's David Faber reported live and on-air that unnamed sources told him that a looming arrangement between Walgreens and private equity firm Sycamore Partners for the latter to buy the former ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback